James C. Bigelow

858 total citations
19 papers, 720 citations indexed

About

James C. Bigelow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, James C. Bigelow has authored 19 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in James C. Bigelow's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and HIV Research and Treatment (2 papers). James C. Bigelow is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and HIV Research and Treatment (2 papers). James C. Bigelow collaborates with scholars based in United States and Japan. James C. Bigelow's co-authors include R. Mark Wightman, Andrew G. Ewing, Joseph A. Near, Aiqun Li, John J. McCormack, David S. Brown, Lynn R. Chrin, Peter P. Roller, Lakshmi Sastry and Tin Cao and has published in prestigious journals such as Science, Journal of Biological Chemistry and Brain Research.

In The Last Decade

James C. Bigelow

19 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Bigelow United States 13 326 322 74 67 67 19 720
Heather A. Enright United States 13 382 1.2× 284 0.9× 31 0.4× 80 1.2× 49 0.7× 27 893
Erika L. Varner United States 10 122 0.4× 177 0.5× 65 0.9× 33 0.5× 27 0.4× 16 432
Jerry C. Chang United States 17 106 0.3× 507 1.6× 11 0.1× 10 0.1× 24 0.4× 29 1.1k
David A. Nagel United Kingdom 19 236 0.7× 361 1.1× 9 0.1× 39 0.6× 16 0.2× 35 818
Anne Meiller France 14 100 0.3× 152 0.5× 88 1.2× 56 0.8× 54 0.8× 20 576
Jianan Chen China 17 162 0.5× 495 1.5× 15 0.2× 28 0.4× 29 0.4× 41 835
Giuseppina Sabatino Italy 15 88 0.3× 591 1.8× 6 0.1× 16 0.2× 88 1.3× 53 1.1k
Naoki Takada Japan 16 173 0.5× 228 0.7× 4 0.1× 104 1.6× 40 0.6× 59 774
Brian L. Robinette United States 12 214 0.7× 140 0.4× 53 0.7× 67 1.0× 7 0.1× 21 690
Kagemasa Kajiwara Japan 15 146 0.4× 339 1.1× 8 0.1× 16 0.2× 39 0.6× 38 581

Countries citing papers authored by James C. Bigelow

Since Specialization
Citations

This map shows the geographic impact of James C. Bigelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Bigelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Bigelow more than expected).

Fields of papers citing papers by James C. Bigelow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Bigelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Bigelow. The network helps show where James C. Bigelow may publish in the future.

Co-authorship network of co-authors of James C. Bigelow

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Bigelow. A scholar is included among the top collaborators of James C. Bigelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Bigelow. James C. Bigelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Holstein, Sarah A., James C. Bigelow, Richard D. Olson, et al.. (2015). Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors. Investigational New Drugs. 33(3). 594–602. 6 indexed citations
2.
Li, Aiqun & James C. Bigelow. (2010). The 7-hydroxylation of dehydroepiandrosterone in rat brain. Steroids. 75(6). 404–410. 16 indexed citations
3.
4.
5.
Bigelow, James C., et al.. (2002). Analytical and pharmacokinetic studies with 5-chloro-2′-deoxycytidine. Biochemical Pharmacology. 64(10). 1493–1502. 22 indexed citations
6.
Howard, O. M. Zack, Joost J. Oppenheim, Melinda G. Hollingshead, et al.. (1998). Inhibition of in Vitro and in Vivo HIV Replication by a Distamycin Analogue That Interferes with Chemokine Receptor Function:  A Candidate for Chemotherapeutic and Microbicidal Application. Journal of Medicinal Chemistry. 41(13). 2184–2193. 66 indexed citations
7.
Beeken, Warren L., Diantha B. Howard, James C. Bigelow, et al.. (1997). Controlled Trial of 4-ASA in Ulcerative Colitis. Digestive Diseases and Sciences. 42(2). 354–358. 15 indexed citations
8.
Lung, Feng‐Di T., Lakshmi Sastry, James C. Bigelow, et al.. (1997). Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain. Journal of Biological Chemistry. 272(46). 29046–29052. 90 indexed citations
9.
10.
Bigelow, James C., et al.. (1990). High-performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 533. 133–140. 41 indexed citations
11.
Beeken, Warren L., et al.. (1990). Luminal concentrations of orally ingested 4‐aminosalicylic acid as determined by in‐vivo equilibrium dialysis. Alimentary Pharmacology & Therapeutics. 4(6). 583–592. 3 indexed citations
12.
Bigelow, James C., J. Calvin Giddings, Yoshikuni Nabeshima, et al.. (1989). Separation of B and T lymphocytes by a hybrid field-flow fractionation/adhesion chromatography technique. Journal of Immunological Methods. 117(2). 289–293. 28 indexed citations
13.
Kristensen, Eric W., James C. Bigelow, & R. Mark Wightman. (1988). Time resolved dopamine overflow from synaptosomes and chopped striatal tissue with rapid superfusion. Brain Research. 461(1). 44–52. 10 indexed citations
14.
Near, Joseph A., James C. Bigelow, & R. Mark Wightman. (1988). Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes.. Journal of Pharmacology and Experimental Therapeutics. 245(3). 921–927. 92 indexed citations
15.
Wilson, Robert L., Katsuo Kamata, James C. Bigelow, George V. Rebec, & R. Mark Wightman. (1986). Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum. Brain Research. 370(2). 393–396. 23 indexed citations
16.
Caudill, W. Lowry, James C. Bigelow, & R. Mark Wightman. (1985). Comparison of release of endogenous dopamine and ?-aminobutyric acid from rat caudate synaptosomes. Neurochemical Research. 10(3). 319–331. 18 indexed citations
17.
Bigelow, James C., David S. Brown, & R. Mark Wightman. (1984). γ‐Aminobutyric Acid Stimulates the Release of Endogenous Ascorbic Acid from Rat Striatal Tissue. Journal of Neurochemistry. 42(2). 412–419. 39 indexed citations
18.
Ewing, Andrew G., James C. Bigelow, & R. Mark Wightman. (1983). Direct in Vivo Monitoring of Dopamine Released from Two Striatal Compartments in the Rat. Science. 221(4606). 169–171. 218 indexed citations
19.
Chao, Julie, Mark Sostek, Kazuaki Shimamoto, et al.. (1980). Kallikrein Content of Rat Pancreatic Acinar Cells or Islets by Direct Radioimmunoassay. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 361(2). 1805–1810. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather A. Enright Breakdown of academic impact, for papers by Erika L. Varner Breakdown of academic impact, for papers by Jerry C. Chang Breakdown of academic impact, for papers by David A. Nagel Breakdown of academic impact, for papers by Anne Meiller Breakdown of academic impact, for papers by Jianan Chen Breakdown of academic impact, for papers by Giuseppina Sabatino Breakdown of academic impact, for papers by Naoki Takada Breakdown of academic impact, for papers by Brian L. Robinette Breakdown of academic impact, for papers by Kagemasa Kajiwara
Rankless by CCL
2026